Komori
Adjuvant Holdings (4929) · RiskMitigated

Risk of inventory write-downs due to slow-moving inventory and declining profitability

First written in FY2023. 2 of 4 entries say "Materialised", first in FY2024-Q2. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2024-Q2 – FY2024-Q32023: 220232024: 120242025: 020252026: 12026
Same theme, other companies
Decline in the Net Realizable Value of InventoriesA theme 206 companies write about · 209 as a headwind · 0 as a tailwind

Adjuvant Holdings moved to the "Worse" side of this theme in 2023, 1 year before the typical company in this theme (2024).

The whole theme swung hardest in 2018: 11 of 37 companies on the "Worse" side.

36 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 210 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「Ending inventory is stated after write-downs due to declining profitability, and the following inventory valuation loss (a negative figure represents a reversal gain) is included in cost of sales. Current consolidated fiscal year: △¥37.172 million」

    The inventory valuation loss resulted in a reversal gain of ¥37.172 million, compared with an inventory valuation loss of ¥74.911 million in the previous fiscal year.
  2. FY2024-Q3MaterialisedAnnual report

    「In terms of profit, although sales increased, inventory write-downs, higher advertising, communications, travel and transportation and depreciation expenses, among others, and an insurance surrender loss resulted in operating profit of ¥94 million, compared with operating profit of ¥242 million in the same period of the previous year, and ordinary profit of ¥101 million, compared with ordinary profit of ¥273 million.」

    An inventory write-down resulting from lower profitability of product inventories was actually cited as a factor reducing profit for the cumulative third-quarter period.
  3. FY2024-Q2MaterialisedAnnual report

    「In terms of profit, although revenue increased, the company recorded an operating loss of ¥92 million, compared with operating profit of ¥33 million in the same period of the previous year, due to increases in inventory write-downs, advertising expenses, communications expenses, research and development expenses and sales promotion expenses, as well as a loss on cancellation of insurance policies.」

    An inventory write-down resulting from lower profitability of product inventories was actually cited as a factor affecting profit for the cumulative second-quarter period.
  4. FY2023First statedAnnual report

    「The amounts for the merchandise and products above are stated after deducting write-downs due to declining profitability of ¥7.623 million in the previous consolidated fiscal year (a negative figure represents a reversal) and ¥39.352 million in the current consolidated fiscal year.」

    The company valued merchandise and products totaling ¥898.279 million using forecasts of future sales and recorded a ¥39.352 million write-down due to declining profitability in the current consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.